论文部分内容阅读
Aims:NVP-BEZ235 is the development of a Novartis ATP competitive inhibition of PI3K/mTOR anticancer drug and inhibition the catalytic activity of Akt and mTOR.This paper introduces the research progress of small molecule inhibitors of anti-tumor.